NCT02182843 - Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Cervical Disc Degenerative Disorder

Interventions

BIOLOGICAL

Cellentra VCBM

Cellentra™ VCBM is an allogenic bone graft containing naturally occurring viable donor cells intended for homologous use in the repair, replacement, reconstruction or supplementation of the recipient's tissue in musculoskeletal defects.

Trial Locations (6)

19107

The Rothman Institute, Philadelphia

42001

Orthopaedic Institute of Western KY, Paducah

43203

Ohio State University Wexner Medical Center, Columbus

46804

Fort Wayne Ortho, Fort Wayne

75032

Spine Team Texas, Southlake

85013

Barrow Neurological Associates, Phoenix